Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
McDermott Will & Schulte said it advised Surgery Partners on its agreement to be acquired by HealthSpan Partners in an all-cash transaction with an enterprise value of approximately $5.7 billion. The firm said the deal involved Surgery Partners’ outpatient surgical business and HealthSpan, an affiliate and supporting organization of Bon Secours Mercy Health.
McDermott Will & Schulte said it advised Lockheed Martin on regulatory matters for its $3.45 billion acquisition of Ultra Maritime. The firm said its team handled antitrust and foreign investment filings across several jurisdictions, supporting a transaction involving undersea and anti-submarine capabilities used by allied navies.
McDermott Will & Schulte said it advised Everspan Group on its agreement to sell Providence Washington Insurance Company to Falvey Insurance Group. The firm described the target as a Rhode Island admitted shell company and said the transaction remains subject to customary closing conditions and required regulatory approvals.
McDermott Will & Schulte said it advised TFP Fertility Group and Amulet Capital Partners on the acquisition of Manchester Fertility Group. The firm said the transaction expanded TFP’s presence in northwest England and supported the group’s fertility services business, which operates clinics in the United Kingdom and Poland.
McDermott Will & Schulte said it advised Mérieux NutriSciences, a food safety, quality and sustainability company, on the completion of its acquisition of Certified Group. The firm said the deal united two complementary leaders in the testing, inspection and certification sector, and it named lawyers from its US offices and its Paris office who worked on the transaction.
McDermott Will & Schulte said partner Andrew Warmus co-authored an article connected with Deloitte’s 2026 Global Divestiture Survey. The firm said the article examines the role of general counsel and chief legal officers in preparing a divestiture before it reaches the market.
McDermott Will & Schulte said it advised Sojourner Consumer Partners and its portfolio company Lornamead on a combination with AMG Brands valued at $279 million. The firm said the transaction brings together businesses that market, manufacture and source consumer products for the home and body.
Gibson Dunn said it advised ATL Partners on acquiring Precise Metal Products from Staple Street Capital. McDermott Will & Schulte said it advised Staple Street on the sale to ATL’s Precise Aerospace & Defense platform, which serves the aerospace, defense and space sectors.
McDermott Will & Schulte said it advised ALPS Insurance on the completion of its acquisition of Ohio Bar Liability Insurance Company. The firm described OBLIC as a provider of professional liability insurance for Ohio attorneys and said the transaction combines its local experience with ALPS’ national operations.
McDermott Will & Schulte said it advised Ecuadorian shrimp producer Omarsa on its acquisition of Spanish group Nueva Pescanova’s chilled products division through production facilities in Boulogne-sur-Mer and Lorient. The firm said its team advised on corporate, public law, tax, competition and employment aspects of the transaction.
McDermott Will & Schulte said Marc Elovitz and John Fitzgerald discussed SEC proposals to expand retail access to private markets in the Financial Times, Ignites and Pensions & Investments. The firm’s account said their commentary addressed performance-based compensation, interval fund rules and share-class structures for registered investment products.
McDermott Will & Schulte said partner David Saunders spoke with StateScoop about the prospects for comprehensive federal privacy legislation. The firm said his interview addressed competing congressional priorities, state concerns about preemption and the possibility that artificial intelligence could prompt renewed attention to privacy issues.
McDermott Will & Schulte said it advised healthcare investor 1315 Capital on a growth investment in Velentium Medical. The firm described Velentium as a developer and manufacturer of medical technologies specializing in active Class II wearable devices and Class III implantable devices.
McDermott said Ele Klein discussed the SEC’s Rule 14a-8 proposal in an interview with Governance Intelligence. The firm’s notice described a discussion about shareholder proposals, the potential role of state law and corporate governing documents, and the costs associated with the proposal process.